Iliac Stent Market Size, Share, By Type (Self-Expandable Stents, Balloon-Expandable Stents, Covered Stents), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By Material (Stainless Steel, Nickel-Titanium (Nitinol), and Cobalt-Chromium), By End-User (Hospitals, Outpatient facilities, and Others), and By Region - Trends, Analysis and Forecast till 2034

Iliac stent market size was valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.3 Billion by 2034, growing at a CAGR of 6.1%

An iliac stent is a small, expandable, tubular medical device used to treat narrowed or blocked iliac arteries, which are significant blood vessels that supply blood to the lower body and legs. Normally, these stents are made of metal mesh or metal covered with fabric and designed to be put inside the diseased artery to help hold it open and restore blood flow properly.

Placing an iliac stent is usually done under local anesthesia and sedation. A catheter is introduced through a small incision in the groin area and advanced to the location of the narrowed or blocked segment of the iliac artery with fluoroscopic guidance. After that, it deploys and expands the stent at a predetermined position when it pushes on the walls of the arteries, opening up the vessel lumen and allowing better blood flow. Over time, it becomes covered with tissue as it is incorporated into the artery wall itself.

Iliac stents are used for peripheral artery disease that has reached the stage of involving the iliac arteries, thus resulting in symptoms such as leg pain, cramping, or fatigue during physical activity. They may also be used in cases of acute limb ischemia or to treat aneurysms in the iliac arteries. This procedure is generally considered minimally invasive compared with open surgery and often results in less time spent in recovery and fewer complications.

While iliac stents significantly improve blood flow and alleviate symptoms, ongoing therapy with blood-thinning medication may be required to prevent blood clots from forming within the stent after a procedure. Follow-up appointments at regular intervals, with repeat imaging studies, are usually necessary to evaluate the performance of the in-place stent further and assure patency of the treated artery.

Key Drivers of Target Market:

Increasing Prevalence of Peripheral Artery Disease (PAD)

• The growth of the iliac stent market is driven by the rise in peripheral artery disease (PAD), a peripheral blood vessel disorder prevailing in the legs. Since PAD has a higher prevalence among the elderly, with the increase in the global aging population, more patients will suffer from PAD. Besides, risk factors for PAD incorporate lifestyle habits, including obesity, smoking, diabetes, and lack of exercise. These factors have become very common worldwide and remain key drivers of demand for iliac stents.

Improvement in the Design and Material of Stent:

• Newer materials like Nitinol have been developed, significantly enhancing stent design. Nitinol is a superelastic alloy with flexible and resilient properties. This makes it possible for iliac stents to be designed so that they are more able to take on the shape of the artery, thus minimizing complications at the time of implantation. Advancements in delivery systems also make it easier and safer to implant iliac stents. These delivery systems were uniquely created to easily travel the vascular system and precisely position the stent within the artery.

Restrains:

Procedural Risks and Complications:

• There are some inherent risks and complications with procedures relating to iliac stent placement. Restenosis is a complication where the treated artery renovates back to its narrowed diameter, decreasing the stent's effectiveness and often resulting in repeat procedures. Stent thrombosis, which is the clotting of blood within the stent, can lead to severe complications such as limb ischemia that may result in amputation. Sometimes, the stent may migrate from its original position and cause blockades or other problems. There is also the risk of infection at the insertion site itself or within the stent, which would necessitate antibiotic treatment.

Opportunities:

Rising Preference for Minimally Invasive Procedures:

• Several advantages associated with minimally invasive procedures are shifting the healthcare landscape towards their application over traditional open surgeries. A few of these benefits include smaller incisions, reduced blood loss, faster recovery time, and less pain for the patient. Therefore, this shift in preference is a significant growth driver for the iliac stent market since iliac artery angioplasty with stent placement is a minimally invasive procedure that offers quickness and is less invasive than traditional bypass surgery.

The market is segmented based on Type, Artery Lesions, Materials, End-User, and Region.

Type Insights:

• Self-Expandable Stents: These stents are designed to expand on their own once they are deployed in the artery. Therefore, these stents are flexible and adaptive since they are made up of materials like Nitinol, making them confirm the artery's natural shape and sustain movements. They are often used in areas where arterial bending and compression are joint.
• Balloon-Expandable Stents: These stents are expanded by a balloon catheter at the site of the lesion and offer accurate placement. They are generally fabricated from stainless steel or cobalt chromium and ordinarily used in conditions where a high degree of accuracy is required to lay stents.
• Covered Stents: Covered stents have a mesh covered with a material that prevents blood from passing through it. They are used in conditions where blood leakage from the mesh of the stent needs to be prevented, such as in cases of aneurysms or perforations in the artery.

Artery Lesions Insights:

• Common Iliac Artery Lesions: These lesions are located in the common iliac artery, the key artery in the pelvis. In this area, stents have to bear rigid support and large pressure arising from blood flow.
• Severe Calcified Lesions: This lesion type has a very high degree of calcification, hardening the artery and making it very tough to treat. The stents used under this condition must be strong enough to penetrate calcified plaques and restore blood flow properly.
• Complete Obstructive Lesions: These are lesions that completely obstruct an artery and require stents that can fully open up to regain the blood vessel's patency. The stents must expand maximally and support maximally to evacuate obstruction effectively.

Material Insights:

• Stainless Steel: These stents are made of stainless steel and, as such, are strong and stiff. They have less flexibility compared to other materials, though. They work best in large, straight arteries and offer rigid support. Since they are cost-effective with their performance already tested, they are widely used.
• Nickel-Titanium (Nitinol): Nickel-titanium stents, known by the brand name Nitinol, have very high flexibility and shape-memory properties. So, they are indicated in arteries that need flexibility and pliability. They can return to their original shape after being compressed, which is advantageous in dynamic vascular environments.
• Cobalt-chromium: These are high-tensile strength stents characterized by radiopacity, which makes them visible under X-ray imaging. Unlike the stainless-steel stent, the cobalt-chromium stent is thinner. Consequently, it provides better deliverability and reduces vessel injury during its placement.

End-User Insights:

• Hospitals: They are the direct and main customers because they have all the comprehensive facilities and specialized personnel to undertake stent implantation procedures. Moreover, they handle more complex cases that require immediate and intensive care.
• Outpatient facilities: These centers offer stent implantation services in a less intensive settings than hospitals. They are suitable for patients requiring fewer complex procedures with a short recovery period; thus, they offer convenience and lower healthcare costs.
• Others: Dedicated clinics and research centers focused on cardiovascular health and treatment. Put another way, these would be centers involved in clinical research programs and would be involved in the development of innovative stent technologies.

Regional Insights

• North America: This region's developed health infrastructure, high healthcare expenditures, and large number of patients affected by cardiovascular diseases place it at the top of the market. This is again reinforced by the presence of key market players.
• Asia Pacific: The Asia Pacific region is one of the fastest-growing markets, driven by rising investments in healthcare, increasing cardiovascular burden, and better access to technologies that involve medical treatment. The key growth contributors to this region include countries such as China and India.
• Europe: Europe comes next in the line of order, holding a pretty considerable market share due to greater awareness about cardiovascular diseases and better healthcare systems. Regulatory support for medical devices further fuels the market growth.
• Latin America: Latin America represents a medium-growth region powered by the improving infrastructure of healthcare and growing awareness about cardiovascular health. However, economic constraints and restricted access to advanced medical technologies might act as a drag on the market's growth.
• Middle East and Africa: Better healthcare facilities and an increasing government interest in improving medical services spur growth. However, economic instability and the unavailability of health care in some regions of the region may hamper the growth of this market.

Iliac Stent Market Report Scope:

Attribute	Details
Market Size 2024	USD 1.3 Billion
Projected Market Size 2034	USD 2.3 Billion
CAGR Growth Rate	6.1%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Type - Self-Expandable Stents, Balloon-Expandable Stents, and Covered Stents. By Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. By Material - Stainless Steel, Nickel-Titanium (Nitinol), and Cobalt-Chromium By End-User - Hospitals, Outpatient facilities, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Type, Artery Lesions, Materials, End-User, and Region.

Segmentation:

By Type:

• Self-Expandable Stents
• Balloon-Expandable Stents
• Covered Stents

By Artery Lesions:

• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions

By Material:

• Stainless Steel
• Nickel-Titanium (Nitinol)
• Cobalt-Chromium

By End-User:

• Hospitals
• Outpatient facilities
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the iliac stent market include Abbott Laboratories, Alvimedica, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co KG, Boston Scientific Corporation, Cook Medical, Getinge AB, iVascular, Medtronic Plc, Terumo Corporation, and W. L. Gore & Associates, Inc.

• In May 2024, the one-year BIONETIC-I study showed that treating the iliac artery with BIOTRONIK's Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System is safe and effective. New findings reported at LINC 2024 support using thin-strut cobalt chromium stents in calcified iliac lesions. The BIONETIC-I results show that the Dynetic-35 stent is safe and efficacious in highly calcified lesions, which is critical when treating iliac arteries.
• In June 2024, Philips launched the Duo Venous Stent System to treat symptomatic venous outflow blockage. Following FDA premarket approval, the Sanger Heart & Vascular Institute at Atrium Health treated the first patient with the innovative implantable medical device. The Duo Venous Stent System, designed for the unique demands of venous architecture and blockages, consists of two stents of varying sizes: Duo Hybrid and Duo Extend. Duo Hybrid is a unique integrated design incorporating numerous zones with varying mechanical qualities into a single stent. These two stents are intended to operate together to reduce the risk of stent fracture and corrosion while providing an option for stent placement in caudal veins with lower dimensions.

• Abbott Laboratories *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Alvimedica
• B. Braun SE
• Becton, Dickinson and Company
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cook Medical
• Getinge AB
• iVascular
• Medtronic Plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Artery Lesions
  • Market Snippet, By Material
  • Market Snippet, By End-User
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Self-Expandable Stents
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Balloon-Expandable Stents
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Covered Stents
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Artery Lesions, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Common Iliac Artery Lesions
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Severe Calcified Lesions
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Complete Obstructive Lesions
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Material, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Stainless Steel
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Nickel-Titanium (Nitinol)
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cobalt-Chromium
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, End-User, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Outpatient facilities
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Artery Lesions, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Material, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Artery Lesions, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Material, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Artery Lesions, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Material, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Artery Lesions, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Material, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Bn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Artery Lesions, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Material, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Abbott Laboratories
• Alvimedica
• B. Braun SE
• Becton, Dickinson and Company
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cook Medical
• Getinge AB
• iVascular
• Medtronic Plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.

The Last Word

• Future Impact
• About Us
• Contact